Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study.
暂无分享,去创建一个
R. Klein | B. Klein | L. Kuller | R. Wallace | L. Hyman | M. Haan | J. Seddon | Yingzi Deng | D. Musch | L. Blythe | R. Klein
[1] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[2] R. Klein,et al. Estrogen replacement therapy and retinal vascular caliber. , 2005, Ophthalmology.
[3] B. Munoz,et al. Hormone Replacement Therapy, Reproductive Factors, and Age-Related Macular Degeneration: The Salisbury Eye Evaluation Project , 2005, Ophthalmic epidemiology.
[4] T. Peto,et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.
[5] Johanna M Seddon,et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.
[6] E. Farish,et al. Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine , 2005, Menopause.
[7] P. McElduff,et al. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy , 2004, Clinical endocrinology.
[8] J. Katz,et al. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey. , 2004, Investigative ophthalmology & visual science.
[9] M. Kulldorff,et al. The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[10] F. Ferris. PROGRESSION OF AGE-RELATED MACULAR DEGENERATION ASSOCIATION WITH DIETARY FAT, TRANSUNSATURATED FAT, NUTS, AND FISH INTAKE , 2004 .
[11] R. Klein,et al. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.
[12] H. Taylor,et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. , 2004, Ophthalmology.
[13] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[14] P. Kertes,et al. POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .
[15] M. C. Leske,et al. Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.
[16] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[17] C. Delcourt,et al. Sex steroids and age-related macular degeneration in older French women: the POLA study. , 2004, Annals of epidemiology.
[18] A. Brzezinski,et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women , 2004, Menopause.
[19] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[20] M. Altındiş,et al. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. , 2003, Maturitas.
[21] Johanna M Seddon,et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.
[22] Garnet L Anderson,et al. The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.
[23] Scott Davis,et al. Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.
[24] B. Rosner,et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. , 2003, Archives of ophthalmology.
[25] R. Klein,et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.
[26] R. Klein,et al. Early age-related maculopathy in the cardiovascular health study. , 2003, Ophthalmology.
[27] J. Seddon,et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. , 2002, American journal of ophthalmology.
[28] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[29] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[30] G. Lip,et al. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. , 2001, Ophthalmology.
[31] L Papoz,et al. Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study , 2001, International Journal of Obesity.
[32] C. Delcourt,et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study , 2001, Ophthalmic epidemiology.
[33] M. Boulton,et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.
[34] R. Klein,et al. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. , 2000, American journal of ophthalmology.
[35] P. Kertes. HYPERTENSION, CARDIOVASCULAR DISEASE, AND AGE-RELATED MACULAR DEGENERATION , 2000 .
[36] M. C. Leske,et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.
[37] E. Barrett-Connor,et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.
[38] J. J. Wang,et al. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. , 1997, Australian and New Zealand journal of ophthalmology.
[39] R. Cumming,et al. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. , 1997, American journal of epidemiology.
[40] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[41] R. Klein,et al. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. , 1994, Transactions of the American Ophthalmological Society.
[42] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[43] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.